http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2010129783-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-24 |
| filingDate | 2008-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2012-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2010129783-A |
| titleOfInvention | GHOST TREATMENT METHODS |
| abstract | 1. A method for treating gout in a subject, the method comprising administering an anti-IL-1β antibody or fragment thereof to the subject. ! 2. The method of claim 1, wherein the gout is chronic gout. ! 3. The method according to claim 1, in which gout is acute gout. ! 4. The method according to claims 1 to 3, in which the antibody or antibody fragment binds human IL-1β with a dissociation constant of about 10 nM or less. ! 5. The method of claim 4, wherein the antibody or antibody fragment binds human IL-1β with a dissociation constant of about 10 nM or less. ! 6. The method of claim 5, wherein the antibody or antibody fragment binds human IL-1β with a dissociation constant of about 500 pM or less. ! 7. The method according to claim 6, in which the antibody or antibody fragment binds human IL-1β with a dissociation constant of approximately 250 pM or less. ! 8. The method of claim 7, wherein the antibody or antibody fragment binds human IL-1β with a dissociation constant of about 10 pM or less. ! 9. The method of claim 8, wherein the antibody or antibody fragment binds human IL-1β with a dissociation constant of about 1 pM or less. ! 10. The method of claim 9, wherein the antibody or antibody fragment binds human IL-1β with a dissociation constant of about 0.5 pM or less. ! 11. The method of claim 10, wherein the antibody or antibody fragment binds human IL-1β with a dissociation constant of about 0.3 pM or less. ! 12. The method according to claims 1-3, 5-11, wherein the anti-IL-1β antibody or antibody fragment is a neutralizing antibody. ! 13. The method according to claims 1-3, 5-11, wherein the anti-IL-1β antibody or antibody fragment binds an epitope of IL-1β, so that |
| priorityDate | 2007-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 39.